Stress, inflammation and cardiovascular disease

Journal of Psychosomatic Research

Volumn 52, Issue 1, 2002, Pages 1-23

  Black, Paul H ^a   Garbutt, Lisa D ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase response; Atherosclerosis; Cytokines; Homocysteine; Lipopolysaccharide; Neurogenic inflammation; Stress; Substance P

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; AUTACOID; C REACTIVE PROTEIN; CATECHOLAMINE; CELL ADHESION MOLECULE; COMPLEMENT; CORTICOSTEROID; CYTOKINE; FIBRINOGEN; GLUCAGON; GLUCOCORTICOID; GROWTH HORMONE; HOMOCYSTEINE; LIPID; LIPOPOLYSACCHARIDE; LIPOPROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; RENIN; SALICYLIC ACID; SERUM AMYLOID A; SUBSTANCE P; TRANSCORTIN; TRANSFERRIN;

ACUTE PHASE RESPONSE; ADAPTATION SYNDROME; ADRENERGIC SYSTEM; ARTERY THROMBOSIS; ARTERY WALL; ATHEROSCLEROSIS; BLOOD CLOTTING; BRAIN; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL ADHESION; CELL TRANSPORT; CHRONIC INFLAMMATION; CONFLICT; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE PRODUCTION; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FIBRINOLYSIS; HORMONE RELEASE; HUMAN; HYPERCOAGULABILITY; HYPOPHYSIS ADRENAL SYSTEM; INFECTION; INFLAMMATION; INFLAMMATORY CELL; LIPID OXIDATION; MACROPHAGE ACTIVATION; MAST CELL; MAST CELL DEGRANULATION; NEUROBIOLOGY; NEUROGENIC INFLAMMATION; NEUROMODULATION; NONHUMAN; PATHOGENESIS; PREDICTION; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN DISORDER; REVIEW; SOCIAL PSYCHOLOGY; STRESS;

ACUTE-PHASE PROTEINS; ADRENAL CORTEX HORMONES; ARTERIOSCLEROSIS; BRAIN; CARDIOVASCULAR DISEASES; CATECHOLAMINES; CYTOKINES; FIBRINOLYSIS; GLUCAGON; HOMOCYSTEINE; HUMAN GROWTH HORMONE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; NEURONS; RENIN; RISK FACTORS; STRESS, PSYCHOLOGICAL; SUBSTANCE P; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0036163590     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(01)00302-6     Document Type: Review

References (287)

1. Emotions and health in occupational life: New scientific findings and policy implications
2. Psychosocial factors: Role in cardiac risk and treatment strategies
3. Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: Population-based study
4. Does low socioeconomic status potentiate the effects of heightened cardiovascular responses to stress on the progression of carotid atherosclerosis?
5. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy
6. Cytokines and growth factors in atherogenesis
7. The pathogenesis of atherosclerosis - An update
8. Atherosclerosis - An inflammatory disease
9. Atherosclerosis, serum cholesterol and the homocysteine theory: A study of 194 consecutive autopsies
10. Role of sympathoadrenal medullary activation in the initiation and progression of atherosclerosis
11. Progression of carotid arteriosclerosis. Three-year follow-up and analysis of risk factors
12. Stress-induced pulse pressure change predicts women's carotid atherosclerosis
13. Stress and pathogenesis of infectious disease
14. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis
15. Immune system - Central nervous system interactions: Effect and immunomodulatory consequences of immune system mediators on the brain
16. Central nervous system - Immune system interactions: Psychoneuroendocrinology of stress and its immune consequences
17. Cytokines for psychologists: Implications for bidirectional immune-to-brain communication for understanding behavior, mood, and cognition
18. The pathogenicity of behavior and its neuroendocrine mediation: An example from coronary artery disease
19. Maternal care, gene expression, and the development of individual differences in stress reactivity
20. Corticotropin-releasing factor in antinociception and inflammation
21. Mast cells in neuroimmune function: Neurotoxicological and neuropharmacological perspectives
22. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves
23. Postnatal development of neurogenic inflammation in the rat
24. Nerve remodelling during intestinal inflammation
25. The interaction between mast cells and nerves in the gastrointestinal tract
26. Neurogenic inflammation in skin and airways
27. Intraneuronal substance P contributes to the severity of experimental arthritis
28. Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides
29. Unilateral rheumatoid arthritis following hemiplegia
30. Asymmetrical rheumatoid arthritis after poliomyelitis
31. Endocrine and vagal controls of sympathetically dependent neurogenic inflammation
32. Further substantiation of a significant role for the sympathetic nervous system in inflammation
33. Modulation by adrenergic transmitters of the efferent function of capsaicin-sensitive nerves in cardiac tissue
34. Cytokines and fever
35. Neuropeptide Y. A novel sympathetic stress hormone and more
36. Local expression of corticotropin-releasing hormone in inflammatory arthritis
37. Substance P and immunoregulation
38. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat spinal cord
39. Immunohistochemical localization of interleukin-6-like immunoreactivity to peripheral nerve-like structures in normal and inflamed human skin
40. Lesion-induced interleukin-6 mRNA expression in rat sciatic nerve
41. Mast cells, neuropeptides and inflammation
42. Mast cells and the nerves - Potential interactions in the context of chronic disease
43. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II
44. Learned histamine release
45. Acute immobilization stress triggers skin mast cell degranulation via corticotropin-releasing factor, neurotensin and substance P: A link to neurogenic skin disorders
46. Nerves and intestinal mast cells modulate responses to enterotoxins
47. Changes in peripheral inflammation induced by CNS actions of an alpha-MSH analog and of endogenous pyrogen
48. Cytokine antagonists in infectious and inflammatory disorders
49. Mechanisms of anti-inflammatory action of the neuroimmunomodulatory peptide alpha-MSH
50. Alpha-MSH in systemic inflammation: Central and peripheral actions
51. Mechanisms of antiinflammatory action of alpha-MSH peptides. In vivo and in vitro evidence
52. Antiinflammatory effects of the neuropeptide alpha-MSH in acute, chronic, and systemic inflammation
53. Inhibition of acute inflammation in the periphery by central action of salicylates
54. Stress, learned helplessness, and brain interleukin-1 beta
55. Task force on behavioral research in cardiovascular, lung, and blood health and disease
56. Hostility and health: Current status of a psychosomatic hypothesis
57. Hostility, CHD incidence, and total mortality: A 25-year follow-up study of 255 physicians
58. Neuroendocrine, cardiovascular, and emotional responses of hostile men: The role of interpersonal challenge
59. Anger and incident heart disease in the Caerphilly study
60. The MRFIT behavior pattern study: II. Type A behavior and incidence of coronary heart disease
61. Biobehavioral basis of coronary-prone behavior in middle-aged men: Part I. Evidence for chronic SNS activation in type As
62. Relationship of cardiovascular activity and anger expression to serum lipid concentrations in healthy young men
63. Biobehavioral basis of coronary-prone behavior in middle-aged men: Part II. Serum cholesterol, the type A behavior pattern, and hostility as interactive modulators of physiological reactivity
64. Neurobiology, cellular and molecular biology, and psychosomatic medicine
65. Heart rate acceleration and its relationship to total serum cholesterol, triglycerides, and blood pressure reactivity in men with mild hypertension
66. Behaviorally elicited heart rate reactivity and atherosclerosis in ovariectomized cynomolgus monkeys (Macaca fascicularis)
67. Epinephrine-mediated increases in plasma cholesterol
68. Acute psychological stress and epinephrine infusion in normolipidemic and hyperlipidemic men: Effects on plasma lipid and apoprotein concentrations
69. Antiatherogenic effects of beta-adrenergic blocking agents: Theoretical, experimental and epidemiologic considerations
70. Psychosocial correlates of job strain in a sample of working women
71. Current issues relating to psychosocial job strain and cardiovascular disease research
72. The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions
73. Protective and damaging effects of stress medicine
74. Vital exhaustion predicts new cardiac events after successful coronary angioplasty
75. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease
76. Psychosocial and biobehavioral characteristics of hypertensive men with elevated atherogenic lipids
77. Immunological consequences of acute and chronic stressors: Mediating role of interpersonal relationships
78. Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys
79. The availability of social support reduces cardiovascular reactivity to acute psychological stress
80. Hopelessness and 4-year progression of carotid atherosclerosis: The Kuopio Ischemic Heart Disease Risk Factor Study
81. Exaggerated blood pressure responses during mental stress are associated with enhanced carotid atherosclerosis in middle-aged Finnish men: Findings from the Kuopio Ischemic Heart Disease Study
82. Exaggerated reactivity to mental stress is associated with exercise-induced myocardial ischemia in an asymptomatic high-risk population
83. Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load
84. Psychosocial factors, sex differences, and atherosclerosis: Lessons from animal models
85. Behavioral antecedents of coronary heart disease and atherosclerosis
86. The natural course of atherosclerosis: Part I. Incidence and progression
87. Individual differences in cellular immune response to stress
88. Social stress and atherosclerosis in normocholesterolemic monkeys
89. Psychosocial factors impair vascular responses of coronary arteries
90. Effects of psychosocial stress on endothelium-mediated dilation of atherosclerotic arteries in cynomolgus monkeys
91. The role of sympathetic activity in atherogenesis: Effects of beta-blockade
92. Experimental sympathetic activation causes endothelial injury in the rabbit thoracic aorta via B1-adrenoceptor activation
93. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina
94. "Variant" angina: One aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients
95. Experiences in assessing estrogen anti-atherogenesis in the chick, the rabbit, and man
96. Adrenal responsiveness and social status in intact and ovariectomized Macaca fascicularis
97. Effects of captopril on atherosclerosis in cynomolgus monkeys
98. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation
99. Endothelial dysfunction in response to psychosocial stress in monkeys
100. Catecholamines, catecholamine receptors, cell adhesion molecules, and acute stressor-related changes in cellular immunity
101. Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter
102. Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells. Effects of mechanical strain on monocyte adhesion to endothelial cells
103. Endothelial-leukocyte adhesion molecules in human disease
104. Learning from the transgenic mouse: Endothelium, adhesive molecules and neointimal formation
105. Regulation of tumor necrosis factor-alpha and interleukin-1 beta-induced adhesion molecule expression in human vascular smooth muscle cells by cAMP
106. Plasma concentration of soluble intercellular adhesion molecule-1 and risks of future myocardial infarction in apparently healthy men
107. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin
108. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) study
109. Shedding from the cell surface of normal and cancer cells
110. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis
111. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis
112. Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis
113. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma
114. Do vascular wall cytokines promote atherogenesis?
115. Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1
116. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
117. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice
118. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
119. Glucocorticoids and stress: Permissive and suppressive actions
120. Glucocorticoids accelerate anti-T-cell receptor-induced T-cell growth
121. Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats
122. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis
123. Hippocampal damage associated with prolonged and fatal stress in primates
124. Adrenal steroid influences on the survival of hippocampal neurons
125. Glucocorticoids, hippocampal damage and glutaminergic synapse
126. Effects of stress on immune cell distribution; Dynamics and hormonal mechanisms
127. Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague-Dawley
128. Stress-induced changes in blood leukocyte distribution; Role of adrenal steroid hormones
129. Glucocorticoid upregulation of high-affinity interleukin-6 receptors on human endothelial cells
130. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics
131. The influence of neuroendocrine pathways on lymphocyte migration
132. Stress and inflammation
133. The effects of psychological stress on plasma interleukin-6 activity in rats
134. Effects of stress on cytokine production
135. Activation of the systemic production of tumor necrosis factor after exposure to acute stress
136. Exposure to physical and psychological stressors elevates plasma interleukin-6: Relationship to the activation of hypothalamic-pituitary-adrenal axis
137. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines
138. Impaired lymphocyte stimulation by mitogens in severely depressed patients
139. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression
140. Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide
141. Effects of psychological stress on serum immunoglobulin, complement and acute phase protein concentrations in normal volunteers
142. Immunosuppression in mice induced by cold water stress
143. Substance P and stress-induced changes in macrophages
144. Substance P primes murine peritoneal macrophages for an augmented proinflammatory cytokine response to lipopolysaccharide
145. Endogenous substance P mediates cold water stress-induced increase in interleukin-6 secretion from peritoneal macrophages
146. Dynamic regulation of proinflammatory cytokines
147. Cytokines, stress, and depression. Conclusions and perspectives
148. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver
149. The relation among stress, adrenalin, interleukin-6 and acute phase reactants in the rat
150. Prolonged effect of psychological disturbance on macrophage chemiluminescence in the squirrel monkey
151. Molecular biology of macrophage activation: A pathway whereby psychological factors can potentially affect health
152. Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes
153. Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro
154. Individual differences in response to LPS and psychological stress in aged rats
155. Bacterial endotoxins and the liver
156. Neurohormonal host defense in endotoxin shock
157. Alpha-adrenergic control of intestinal circulation in heat-stressed baboons
158. Hypoxia-induced endotoxemia in primates: Role of reticuloendothelial system function and anti-lipopolysaccharide plasma
159. Changes in lipopolysaccharide concentrations in hepatic portal and systemic plasma during intestinal ischemia in monkeys
160. The effect of ischemia of the dog's colon on transmural migration of bacteria and endotoxin
161. Time course of endotoxemia and cardiovascular changes in heat-stressed primates
162. Prenatal manipulations reduce the proinflammatory response to a cytokine challenge in juvenile monkeys
163. Acute and subacute effects of endotoxin on hypothalamic gaseous neuromodulators
164. The autonomic nervous system as a communication channel between the brain and immune system
165. Beta blockers, plasma lipids and coronary heart disease
166. Components of the protein fraction of oxidized low-density lipoprotein stimulate interleukin-1 alpha production by rabbit arterial macrophage-derived foam cells
167. Hepatocyte nitric oxide production is induced by Kupffer cells
168. Translocation of platelets into disse spaces and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor: The role of Kupffer cells
169. The acute phase response
170. The role of the adrenals in the acute phase response to interleukin-1 and tumor necrosis factor alpha
171. Restraint-induced stress elicits acute phase response in rabbits
172. Modulatory effects of glucocorticoid and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications
173. Semantics, inflammation, cytokines and common sense
174. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
175. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
176. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project
177. Inflammation, aspirin, and the risk of cardiovascular disease in apparently health men
178. Elevation of C-reactive protein in "active" coronary artery disease
179. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
180. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes
181. Intrinsic fibrinolytic capacity and systemic inflammation: Novel risk factors for arterial thrombotic disease
182. Macrophage infiltration in acute coronary syndromes
183. Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin - Biotin staining method
184. Characterization and isolation of a C-reactive protein receptor from the human monocyte cell line U-937
185. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
186. Regulation of serum amyloid A protein expression during the acute phase response
187. Acute phase proteins and other systemic responses to inflammation
188. Serum amyloid A (SAA) influence on HDL-mediated cellular cholesterol efflux
189. Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice
190. Human serum amyloid A has cytokine-like properties
191. Ribozyme mediated cleavage of acute phase serum amyloid A (A-SAA) mRNA in vitro
192. Expression of serum amyloid A genes in mink during induction of inflammation and amyloidosis
193. The inflammation and coagulation: Linked processes potentially regulated through a common pathway by protein C
194. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men
195. Work stress and metabolic and hemostatic risk factors
196. Changes of plasma coagulation and fibrinolysis in response to mental stress
197. Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression
198. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin
199. Anti-platelet activity of beta-adrenergic antagonists: Inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment
200. Possible role of platelets
201. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
202. Prospective study of endogenous tissue plasminogen activator and risk of stroke
203. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography
204. Fibrinolytic activity, clotting factors and long term incidence of ischemic heart disease in the Northwick Park Heart Study
205. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study
206. PAI-1, obesity, insulin resistance and risk of cardiovascular events
207. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function
208. Complement C5b-9 increases plasminogen binding and activation on human endothelial cells
209. Pathophysiology of coronary artery disease
210. Plasma fibrinogen and ischemic heart disease risk factors
211. Fibrinogen and its relations to subclinical extracoronary and coronary atherosclerosis in hypercholesterolemic men
212. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
213. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from the Cardiovascular Health Study
214. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway
215. Evidence that brief stress may induce the acute phase response in rats
216. Dynamic variations in plasma corticosteroid-binding globulin and basal HPA activity following acute stress in adult rats
217. A long-term increase in basal levels of corticosterone and a decrease in corticosteroid-binding globulin after acute stressor exposure
218. Corticosteroid-binding globulin during inflammation and burn injury: Nutritional modulation and clinical implications
219. Chronic social stress produces reductions in available splenic type II corticosteroid receptor binding and plasma corticosteroid binding globulin levels
220. Corticosteroid-binding globulin synthesis regulation by cytokines and glucocorticoids in human hepatoblastoma-derived (HepG2) cells
221. Decreased corticosteroid-binding globulin in burn patients: Relationship with interleukin-6 and fat in nutritional support
222. Inhibition of corticosteroid-binding globulin caused by a severe stressor is apparently mediated by the adrenal but not by glucocorticoid receptors
223. Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo
224. Iron status and risk of cardiovascular disease
225. Iron and LDL oxidation in atherogenesis
226. Metabolic response to injury and sepsis: Changes in protein metabolism
227. Low iron-binding capacity as a risk factor for myocardial infarction
228. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy
229. Variations in plasma lipid concentration during examination stress
230. Lipids, personality and stress: Mechanisms and modulators
231. Lipid reactivity to stress: I. Comparison of chronic and acute stress responses in middle-aged airline pilots
232. Lipid reactivity to stress: II. Biological and behavioral influences
233. Human very-low-density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice
234. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins
235. A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits
236. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death
237. Effects of endotoxin and cytokines on lipid metabolism
238. Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis
239. Stress and lipoprotein metabolism: Modulators and mechanisms
240. Variability of plasma lipids in response to emotional arousal
241. Importance of beta-adrenoceptor function in fat cells for lipid mobilization
242. The function of the plasma triglycerides in fatty acid transport
243. Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion
244. Psychosocial stress and the insulin resistance syndrome
245. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin
246. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells
247. Earthquake and coronary heart disease risk factors: A longitudinal study
248. Earthquake-induced cardiovascular disease and related risk factors in focusing on the Great Hanshin-Awaji Earthquake
249. The nature of the epinephrine-induced hyperlipidemia in dogs and its modification by glucose
250. Association of blood pressure variability with induction of atherosclerosis in cholesterol-fed rats
251. Lipids in psychological research: The last decade
252. Homocysteine theory of arteriosclerosis
253. Homocysteine and vascular disease
254. Homocysteine and atherothrombosis
255. Histopathological effects of homocysteine thiolactone on epithelial and stromal tissues
256. Plasma homocysteine levels increase in women during psychological stress
257. IgE-dependent generation of foam cells: An immune mechanism involving degranulation of sensitized mast cells with resultant uptake of LDL by macrophages
258. Mast cell granule remnants carry LDL into smooth muscle cells of the synthetic phenotype and induce their conversion into foam cells
259. Mast cells in human fatty streaks and atheromas: Implications for intimal lipid accumulation
260. Chymase-containing mast cells in human arterial intima: Implications for atherosclerotic disease
261. The role of mast cells in atherosclerosis
262. CRF receptor regulation and sensitization of ACTH responses to acute ether stress during chronic intermittent immobilization stress
263. Dexamethasone resistance among nonhuman primates associated with a selective decrease of glucocorticoid receptors in the hippocampus and a history of social instability
264. Catecholamines, stress, and disease: A psychobiological perspective
265. Price of adaptation - Allostatic load and its health consequences. MacArthur studies of successful aging
266. Depression as a risk factor for cardiac events in established coronary heart disease: A review of possible mechanisms
267. Coronary heart disease in women: Personality and stress-induced biological responses
268. Depression and the risk of coronary heart disease in the normative aging study
269. Depression and the course of coronary artery disease
270. Effects of depressive disorders on coronary artery disease: A review
271. The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment
272. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: Relationship with immune-inflammatory markers
273. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis
274. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression
275. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients
276. Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery
277. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
278. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women
279. Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
280. Psychoneuroimmunology: Brain and immunity
281. Effects of estrogens on the redox chemistry of iron: A possible mechanism of the antioxidant action of steroids
282. Novel scavestrogens and their radical scavenging effects, iron chelating and total antioxidant activities: Delta 8-9-dehydroderivatives of 17 alpha-estradiol and 17 beta-estradiol
283. The importance of beta-adrenergic receptors in immune regulation: A link between neuroendocrine and immune system
284. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: A biobehavioral pathway to coronary artery disease?
285. The endotoxin-lipoprotein hypothesis
286. Effects of seasonal mood changes on seasonal variations in coronary heart disease: Role of immune system, infection and inflammation